Medoflucon (Fluconazole)

Fluconazole inhibits the fungal cytochrome P450 enzyme lanosterol 14α‑demethylase, which is essential for converting lanosterol to ergosterol, a key component of the fungal cell membrane. By disrupting ergosterol synthesis, the drug compromises membrane integrity, leading to inhibited growth and eventual death of susceptible fungi.

The dosage of Medoflucon is determined by the prescribing clinician based on the specific infection, patient age, weight, renal and hepatic function, and other clinical factors. Physicians select the appropriate strength and duration according to approved guidelines and individual patient needs.

Safety of fluconazole in pregnancy and lactation depends on the dose and trimester. High‑dose or prolonged therapy may be associated with fetal risk, while single low‑dose regimens are sometimes considered acceptable. Breastfeeding mothers should discuss potential exposure with their healthcare provider before use.

To place an order, submit an enquiry on the Medoflucon product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with polyene antifungals such as amphotericin B, fluconazole offers oral administration, better tolerability and fewer infusion‑related reactions, but it has a narrower spectrum against certain molds. Compared to echinocandins, fluconazole is less potent for invasive candidiasis but is more convenient for outpatient treatment of susceptible organisms.

Medoflucon should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiration date printed on the label.

Medoflucon is taken by mouth, usually with or without food, as directed by the prescribing clinician. The tablet should be swallowed whole with a glass of water and not chewed or crushed unless specifically instructed. Adherence to the prescribed schedule is important for optimal therapeutic outcome.

Serious adverse reactions, although rare, include severe liver injury, Stevens‑Johnson syndrome, toxic epidermal necrolysis, severe allergic reactions such as anaphylaxis, and hematologic abnormalities like agranulocytosis. Patients should seek immediate medical attention if they develop jaundice, rash, fever, or unexplained bleeding while on therapy.

Medoflucon is contraindicated in individuals with known hypersensitivity to fluconazole or any azole antifungal. Caution is advised for patients with significant hepatic impairment, those taking medications that have major interactions, and pregnant women unless the potential benefit justifies the risk. Clinicians should evaluate each patient’s medical history before prescribing.